Reminder systems and late patient tracers in the diagnosis and management of tuberculosis

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2007, Pages

  Liu, Qin ^a   Abba, K ^b   Alejandria, M M ^b   Balanag, V M ^b   Berba, R P ^b   Lansang, M A ^b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

CLINICAL PROTOCOL; DIAGNOSTIC PROCEDURE; DIRECTLY OBSERVED THERAPY; HUMAN; INFECTION PREVENTION; LUNG TUBERCULOSIS; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT EDUCATION; PATIENT REFERRAL; REVIEW; SPUTUM ANALYSIS; SPUTUM CULTURE; TUBERCULIN TEST;

EID: 44949163016     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006594     Document Type: Review

References (20)

1. Bosch Capblanch 2006 Bosch Capblanch X, Garner P. Contracts between patients and healthcare practitioners for improving patients' adherence to treatment, prevention and health promotion activities (Protocol). Cochrane Database of Systematic Reviews 2006, Issue 4.
2. Goble 1993 Goble M, Iseman MD, Madsen LA, Waite D, Ackerson L, Horsburgh CR Jr. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. New England Journal of Medicine 1993;328(8):527-32.
3. Green 2003 Green D. ICT-enabled development case studies series: The compliance service uses SMS technology for TB treatment. www.bridges.org/case_studies/137 2003 (accessed 1 September 2006).
4. Haynes 2005 Haynes RB, Yao X, Degani A, Kripalani S, Garg A, McDonald HP. Intervention for enhancing medication adherence. Cochrane Database of Systematic Reviews 2005, Issue 4.
5. Higgins 2006 Higgins J, Green S, editors. Highly sensitive search strategies for identifying reports of randomized controlled trials in MEDLINE. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]; Appendix 5b. www.cochrane.org/resources/handbook/hbook.htm (accessed 1 March 2006).
6. Jagota 1996 Jagota P, Sreenivas TR, Parimala N. Improving treatment compliance by observing difference in treatment irregularity. Indian Journal of Tuberculosis 1996;43:75-80.
7. Johansson 1999 Johansson E, Long NH, Diwan VK, Winkvist A. Attitudes to compliance with tuberculosis treatment among women andmen in Vietnam. International Journal of Tuberculosis and Lung Disease 1999;3 (10):862-8.
8. Juni 2001 Juni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 2001;323(7303):42-6.
9. M'Imunya 2007 M'Imunya MJ, Volmink J. Education and counselling for promoting adherence to the treatment of active tuberculosis (Protocol). Cochrane Database of Systematic Reviews 2007, Issue 3.
10. Mitchison 1998 Mitchison DA. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. International Journal of Tuberculosis and Lung Disease 1998;2(1):10-5.
11. O'Boyle 2002 O'Boyle SJ, Power JJ, Ibrahim MY, Watson JP. Factors affecting patient compliance with anti-tuberculosis chemotherapy using the directly observed treatment, short-course strategy (DOTS). International Journal of Tuberculosis and Lung Disease 2002;6(4):307-12.
12. Ormerod 1991 Ormerod LP, Prescott RJ. Inter-relations between relapses, drug regimens and compliance with treatment in tuberculosis. Respiratory Medicine 1991;85(3):239-42.
13. Review Manager 4.2 The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 4.2 for Windows. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2003.
14. Thilakavathi 1993 Thilakavathi S, Fredrick JS, Fredrick KG, Parthasarathy R, Santha T. High coverage for long term follow-up of patients with spinal tuberculosis. Indian Journal of Tuberculosis 1993;40(2):91-4.
15. Volmink 2006 Volmink J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database of Systematic Reviews 2006, Issue 2.Art. No.: CD003343. DOI:10.1002/14651858.CD003343.pub3.
16. Weis 1994 Weis SE, Slocum PC, Blais FX, King B, Nunn M, Matney GB, et al.The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. New England Journal of Medicine 1994;330(17):1179-84.
17. WHO 2003 WHO Global Tuberculosis Programme. Treatment of tuberculosis: guidelines for national programmes [WHO/CDS/TB/2003.313]. 3rd Edition. Geneva: World Health Organization, 2003.
18. WHO 2006a World Health Organization. 2006 Tuberculosis facts [WHO/HTM/STB/factsheet/2006.1]; www.who.int/tb/publications/2006/ tb_factsheet_2006_1_en.pdf. Geneva: World Health Organization, 2006 (accessed 1 September 2006).
19. WHO 2006b Stop TB Partnership and World Health Organization. The global plan to stop TB, 2006-2015 [WHO/HTM/STB/2006.35]. Geneva:World Health Organization, 2006.
20. WHO 2006c World Health Organization, Communicable Diseases Cluster. Global tuberculosis control: surveillance, planning, financing : WHO report 2006 [WHO/HTM/TB/2006.362]. Geneva: World Health Organization, 2006.